Placebo-Controlled Comparison of Two Different Brands of Modified-Release Oral Dosage Forms Regarding Safety and Efficacy in Children With Attention Deficit Hyperactivity Disorder (ADHD) Aged 6 - 14
Clinical trial NCT00254878 · COMPLETED
Trial details
- NCT number
- NCT00254878
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.